Uppenberg J, Svensson C, Jaki M, Bertilsson G, Jendeberg L, Berkenstam A
Department of Structural Chemistry, Pharmacia and Upjohn, Lindhagensgatan 133, S-112 87 Stockholm, Sweden.
J Biol Chem. 1998 Nov 20;273(47):31108-12. doi: 10.1074/jbc.273.47.31108.
The peroxisome proliferator-activated receptors (PPAR) are members of the nuclear receptor supergene family and are considered as key sensors of both lipid and glucose homeostasis. The role of the PPARgamma isoform in glucose metabolism is illustrated by the fact that anti-diabetic thiazolidinediones have been shown to be bona fide PPARgamma ligands. Here we report the crystal structure of apo-PPARgamma ligand binding domain (LBD) determined to 2.9-A resolution. Although the structure of apo-PPARgamma-LBD retains the overall fold described previously for other nuclear receptor LBDs, three distinct structural differences are evident. 1) The core AF-2 activation domain of apo-PPARgamma LBD is folded back toward the predicted ligand binding pocket similar to that observed in the holo-forms of other nuclear receptors. 2) The proposed ligand binding pocket of apo-PPARgamma-LBD is larger and more accessible to the surface in contrast to other LBDs. 3) The region of the LBD called the omega-loop is extended in PPARgamma and contains additional structural elements. Taken together, the apo-PPARgamma-LBD structure is in several aspects different from previously described LBDs. Given the central role of PPARgamma as a mediator in glucose regulation, the structure should be an important tool in the development of improved anti-diabetic agents.
过氧化物酶体增殖物激活受体(PPAR)是核受体超基因家族的成员,被认为是脂质和葡萄糖稳态的关键传感器。抗糖尿病噻唑烷二酮类药物已被证明是真正的PPARγ配体,这一事实说明了PPARγ亚型在葡萄糖代谢中的作用。在此,我们报告了无配体PPARγ配体结合域(LBD)的晶体结构,其分辨率为2.9埃。尽管无配体PPARγ-LBD的结构保留了先前描述的其他核受体LBD的整体折叠,但明显存在三个不同的结构差异。1)无配体PPARγ LBD的核心AF-2激活域向预测的配体结合口袋折叠,类似于在其他核受体的全酶形式中观察到的情况。2)与其他LBD相比,无配体PPARγ-LBD的拟配体结合口袋更大,且更容易接近表面。3)LBD中称为ω环的区域在PPARγ中延伸,并包含额外的结构元件。综上所述,无配体PPARγ-LBD的结构在几个方面与先前描述的LBD不同。鉴于PPARγ作为葡萄糖调节介质的核心作用,该结构应成为开发改良抗糖尿病药物的重要工具。